Life sciences briefing: Wednesday, Jan. 23, 2008
TODAY’S HEADLINES:
Mauna Kea Tech raises $30M for in-vivo cellular imaging (release)
Knopp Neuro takes in $10M for Lou Gehrig’s drug (release)
Cardiovascular Systems, arterial-plaque device maker, files for $86M IPO (Edgar)
Diagnostics maker BG Medicine withdraws IPO (release)
Signature Genomics Labs sells stake to Ampersand Ventures (release)
Cambridge Temp raises £375K for new ovulation detector (release)
Mauna Kea Tech raises $30M for in-vivo cellular imaging — Mauna Kea Technologies, a Paris, France, developer of cellular-imaging technology, raised $30 million in a… Continue Reading
Life sciences briefing: Thursday, Oct. 11, 2007
Featured companies: Ablynx, Bind Biosciences, Maas Biolab, Oriel Therapeutics, ThromboVision, Xcellerex
(UPDATED: See below.)
Contract biomanufacturer Xcellerex pulls in $31M — Marlborough, Mass.-based Xcellerex, a startup that provides contract “bioprocess” development and manufacturing, raised $31 million in a third funding round. Investors included VantagePoint Venture Partners, Kleiner Perkins Caufield and Byers, and SCG Investments.
Xcellerex develops modular “turnkey” manufacturing systems for complex biomolecules such as the proteins, peptides, antibodies and nucleic acids used in biotech drugs and vaccines. The… Continue Reading